- Home
- RAYA vs SRZN Comparison
RAYA vs SRZN Comparison
Compare RAYA & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- SRZN
- Stock Information
- Founded
- RAYA 2019
- SRZN 2015
- Country
- RAYA China
- SRZN United States
- Employees
- RAYA N/A
- SRZN N/A
- Industry
- RAYA Metal Fabrications
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- RAYA Consumer Discretionary
- SRZN Health Care
- Exchange
- RAYA Nasdaq
- SRZN Nasdaq
- Market Cap
- RAYA 34.2M
- SRZN 82.8M
- IPO Year
- RAYA 2022
- SRZN N/A
- Fundamental
- Price
- RAYA $1.44
- SRZN $10.03
- Analyst Decision
- RAYA
- SRZN Strong Buy
- Analyst Count
- RAYA 0
- SRZN 2
- Target Price
- RAYA N/A
- SRZN $38.50
- AVG Volume (30 Days)
- RAYA 18.5K
- SRZN 10.7K
- Earning Date
- RAYA 01-01-0001
- SRZN 05-07-2025
- Dividend Yield
- RAYA N/A
- SRZN N/A
- EPS Growth
- RAYA N/A
- SRZN N/A
- EPS
- RAYA N/A
- SRZN N/A
- Revenue
- RAYA $30,300,360.00
- SRZN $10,655,000.00
- Revenue This Year
- RAYA $64.53
- SRZN N/A
- Revenue Next Year
- RAYA $9.61
- SRZN N/A
- P/E Ratio
- RAYA N/A
- SRZN N/A
- Revenue Growth
- RAYA N/A
- SRZN N/A
- 52 Week Low
- RAYA $0.56
- SRZN $6.00
- 52 Week High
- RAYA $1.90
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- RAYA 52.16
- SRZN 46.52
- Support Level
- RAYA $1.44
- SRZN $9.57
- Resistance Level
- RAYA $1.90
- SRZN $10.58
- Average True Range (ATR)
- RAYA 0.16
- SRZN 0.59
- MACD
- RAYA 0.01
- SRZN 0.07
- Stochastic Oscillator
- RAYA 41.03
- SRZN 68.59
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).